Immediate Impact
15 standout
Citing Papers
Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023
2024 Standout
Rheumatoid arthritis
2023 Standout
Works of Ify Sargeant being referenced
Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action
2015
Variation in the use of biologics in the management of rheumatoid arthritis across the UK
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ify Sargeant | 182 | 22 | 106 | 58 | 18 | 332 | |
| Marc Boutin | 160 | 6 | 151 | 64 | 16 | 321 | |
| Mahlet G. Tebeka | 70 | 15 | 88 | 28 | 16 | 272 | |
| M Drummond | 90 | 15 | 192 | 25 | 20 | 308 | |
| Félix Lobo | 94 | 40 | 117 | 31 | 26 | 334 | |
| Hans-Martin Späth | 48 | 11 | 100 | 23 | 19 | 281 | |
| Wendy Selig | 68 | 3 | 80 | 48 | 15 | 267 | |
| Rick J. Carlson | 119 | 3 | 142 | 47 | 21 | 350 | |
| J Neuman | 38 | 5 | 79 | 122 | 13 | 301 | |
| Angelyn Fairchild | 58 | 7 | 137 | 28 | 20 | 320 | |
| Jasper Ubels | 53 | 10 | 109 | 39 | 11 | 367 |
All Works
Login with ORCID to disown or claim papers
Loading papers...